Joint Action Personalised Cancer Medicine opens the door to private sector stakeholders
10:43 by Lieve DESSING (Sciensano)The Joint Action Personalised Cancer Medicine (JA PCM) welcomed industry stakeholders to the webinar " : & ." It was an engaging session in which consortium representatives presented the pilot activities currently underway and shared concrete...